nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenylpyraline—Cyclizine—SULT1E1—prostate cancer	0.0434	0.269	CrCbGaD
Diphenylpyraline—Bifonazole—CYP17A1—prostate cancer	0.0146	0.091	CrCbGaD
Diphenylpyraline—Phenoxybenzamine—SLC22A3—prostate cancer	0.00761	0.0473	CrCbGaD
Diphenylpyraline—Bifonazole—CYP19A1—prostate cancer	0.00745	0.0463	CrCbGaD
Diphenylpyraline—Diphenhydramine—CYP2C18—prostate cancer	0.0056	0.0348	CrCbGaD
Diphenylpyraline—Bifonazole—CYP2E1—prostate cancer	0.00556	0.0345	CrCbGaD
Diphenylpyraline—Bifonazole—CYP2C19—prostate cancer	0.0055	0.0342	CrCbGaD
Diphenylpyraline—Phenoxybenzamine—SLC22A1—prostate cancer	0.00546	0.0339	CrCbGaD
Diphenylpyraline—Modafinil—CYP3A5—prostate cancer	0.00531	0.033	CrCbGaD
Diphenylpyraline—Fentanyl—CYP3A5—prostate cancer	0.0052	0.0323	CrCbGaD
Diphenylpyraline—Cinnarizine—CYP2A6—prostate cancer	0.00498	0.0309	CrCbGaD
Diphenylpyraline—Reboxetine—CYP3A4—prostate cancer	0.00491	0.0305	CrCbGaD
Diphenylpyraline—Benzatropine—CYP2C19—prostate cancer	0.00488	0.0303	CrCbGaD
Diphenylpyraline—Diphenhydramine—SLC22A1—prostate cancer	0.00457	0.0284	CrCbGaD
Diphenylpyraline—Modafinil—CYP2C19—prostate cancer	0.00362	0.0225	CrCbGaD
Diphenylpyraline—Bifonazole—CYP3A4—prostate cancer	0.0035	0.0217	CrCbGaD
Diphenylpyraline—Cinnarizine—CYP1A1—prostate cancer	0.00349	0.0216	CrCbGaD
Diphenylpyraline—Phenoxybenzamine—ADRB2—prostate cancer	0.00348	0.0216	CrCbGaD
Diphenylpyraline—Atomoxetine—CYP2C19—prostate cancer	0.00311	0.0193	CrCbGaD
Diphenylpyraline—SLC6A3—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.0029	0.00346	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—PLCB2—prostate cancer	0.00288	0.00343	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—MC2R—prostate cancer	0.00285	0.00339	CbGpPWpGaD
Diphenylpyraline—HRH1—IL-4 Signaling Pathway—PIK3CD—prostate cancer	0.00284	0.00338	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—GNG5—prostate cancer	0.00284	0.00338	CbGpPWpGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—RXRA—prostate cancer	0.00282	0.00337	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—LPAR1—prostate cancer	0.00282	0.00336	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—prostate cancer	0.00282	0.00336	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00281	0.00335	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB2—prostate cancer	0.00279	0.00333	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—SLC22A1—prostate cancer	0.00275	0.00327	CbGpPWpGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—GSTP1—prostate cancer	0.00271	0.00323	CbGpPWpGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—TGFBR2—prostate cancer	0.00271	0.00323	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—GRPR—prostate cancer	0.00264	0.00315	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—GNG5—prostate cancer	0.00261	0.00311	CbGpPWpGaD
Diphenylpyraline—HRH1—IL-4 Signaling Pathway—JAK2—prostate cancer	0.0026	0.0031	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—prostate cancer	0.00254	0.00303	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNG5—prostate cancer	0.00254	0.00302	CbGpPWpGaD
Diphenylpyraline—Diphenhydramine—CYP2C19—prostate cancer	0.00251	0.0156	CrCbGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—GSTM1—prostate cancer	0.00249	0.00297	CbGpPWpGaD
Diphenylpyraline—Orphenadrine—CYP2E1—prostate cancer	0.0024	0.0149	CrCbGaD
Diphenylpyraline—SLC6A3—Neuronal System—ACHE—prostate cancer	0.00233	0.00277	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—ANXA1—prostate cancer	0.00232	0.00277	CbGpPWpGaD
Diphenylpyraline—Modafinil—CYP3A4—prostate cancer	0.0023	0.0143	CrCbGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00229	0.00273	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—WNT4—prostate cancer	0.00227	0.00271	CbGpPWpGaD
Diphenylpyraline—Fentanyl—CYP3A4—prostate cancer	0.00225	0.014	CrCbGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—OR51E2—prostate cancer	0.00224	0.00267	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00223	0.00266	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00223	0.00266	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—PRKACB—prostate cancer	0.00223	0.00265	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—MC2R—prostate cancer	0.00217	0.00259	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—prostate cancer	0.00216	0.00257	CbGpPWpGaD
Diphenylpyraline—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.00212	0.00253	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—COMT—prostate cancer	0.00212	0.00252	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—GRP—prostate cancer	0.00209	0.00249	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—LPAR1—prostate cancer	0.00209	0.00249	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—prostate cancer	0.00208	0.00248	CbGpPWpGaD
Diphenylpyraline—HRH1—IL-4 Signaling Pathway—EP300—prostate cancer	0.00204	0.00243	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—OR51E2—prostate cancer	0.00203	0.00242	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—prostate cancer	0.00203	0.00242	CbGpPWpGaD
Diphenylpyraline—Benzphetamine—CYP3A4—prostate cancer	0.00199	0.0124	CrCbGaD
Diphenylpyraline—Atomoxetine—CYP3A4—prostate cancer	0.00198	0.0123	CrCbGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—PRKCQ—prostate cancer	0.00194	0.00231	CbGpPWpGaD
Diphenylpyraline—Mianserin—CYP3A4—prostate cancer	0.00193	0.012	CrCbGaD
Diphenylpyraline—HRH1—GPCR ligand binding—PENK—prostate cancer	0.00193	0.0023	CbGpPWpGaD
Diphenylpyraline—HRH1—IL-4 Signaling Pathway—STAT3—prostate cancer	0.00191	0.00228	CbGpPWpGaD
Diphenylpyraline—Phenoxybenzamine—CYP3A4—prostate cancer	0.00191	0.0118	CrCbGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—RGS17—prostate cancer	0.0019	0.00227	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00181	0.00216	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—prostate cancer	0.00173	0.00207	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—RGS17—prostate cancer	0.00173	0.00206	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—ITPR1—prostate cancer	0.00172	0.00205	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—RLN2—prostate cancer	0.0017	0.00202	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.00167	0.00199	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—GNRH1—prostate cancer	0.00164	0.00196	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—COMT—prostate cancer	0.00162	0.00193	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—LPAR1—prostate cancer	0.00159	0.0019	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—GRP—prostate cancer	0.00159	0.0019	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PLXNB1—prostate cancer	0.00155	0.00185	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CX3CL1—prostate cancer	0.00155	0.00184	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—prostate cancer	0.00154	0.00184	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—RLN2—prostate cancer	0.00154	0.00183	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—prostate cancer	0.00154	0.00183	CbGpPWpGaD
Diphenylpyraline—Orphenadrine—CYP3A4—prostate cancer	0.00151	0.00938	CrCbGaD
Diphenylpyraline—HRH1—IL-4 Signaling Pathway—PIK3CA—prostate cancer	0.00151	0.0018	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GRPR—prostate cancer	0.00149	0.00178	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.00148	0.00176	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—GNG5—prostate cancer	0.00143	0.0017	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—prostate cancer	0.00141	0.00168	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PLXNB1—prostate cancer	0.00141	0.00168	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—prostate cancer	0.00141	0.00168	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—GNG5—prostate cancer	0.0014	0.00167	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GRPR—prostate cancer	0.00136	0.00162	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—PTHLH—prostate cancer	0.00125	0.00148	CbGpPWpGaD
Diphenylpyraline—HRH1—IL-4 Signaling Pathway—AKT1—prostate cancer	0.00123	0.00147	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—MC2R—prostate cancer	0.00123	0.00146	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—prostate cancer	0.00121	0.00144	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—OR51E2—prostate cancer	0.0012	0.00143	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.0012	0.00143	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—ANXA1—prostate cancer	0.00117	0.0014	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—WNT4—prostate cancer	0.00117	0.00139	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—MDM2—prostate cancer	0.00113	0.00135	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.00113	0.00135	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—MC2R—prostate cancer	0.00111	0.00133	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—BMPR1B—prostate cancer	0.0011	0.00131	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CALCA—prostate cancer	0.0011	0.00131	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PENK—prostate cancer	0.00109	0.0013	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.00108	0.00128	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CXCL12—prostate cancer	0.00107	0.00128	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—RGS17—prostate cancer	0.00102	0.00122	CbGpPWpGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—TGFB1—prostate cancer	0.00101	0.00121	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PENK—prostate cancer	0.000992	0.00118	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000951	0.00113	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—prostate cancer	0.000946	0.00113	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—VIP—prostate cancer	0.000929	0.00111	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GNRH1—prostate cancer	0.000929	0.00111	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—ADRB2—prostate cancer	0.000919	0.0011	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—RLN2—prostate cancer	0.000909	0.00108	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000905	0.00108	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GRP—prostate cancer	0.0009	0.00107	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—LPAR1—prostate cancer	0.0009	0.00107	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PLCB2—prostate cancer	0.000891	0.00106	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HSD17B1—prostate cancer	0.000868	0.00103	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CTBP2—prostate cancer	0.000868	0.00103	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—MDM2—prostate cancer	0.000867	0.00103	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—prostate cancer	0.000862	0.00103	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PDE4D—prostate cancer	0.00085	0.00101	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GNRH1—prostate cancer	0.000844	0.00101	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—VIP—prostate cancer	0.000844	0.00101	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PLXNB1—prostate cancer	0.000832	0.000991	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—LPAR1—prostate cancer	0.000817	0.000974	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GRP—prostate cancer	0.000817	0.000974	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PLCB2—prostate cancer	0.000809	0.000964	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GNG5—prostate cancer	0.000808	0.000963	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRPR—prostate cancer	0.000801	0.000954	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CX3CL1—prostate cancer	0.000793	0.000945	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IL17RD—prostate cancer	0.000773	0.000922	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PDE4D—prostate cancer	0.000772	0.00092	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GNG5—prostate cancer	0.000734	0.000875	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PTHLH—prostate cancer	0.000704	0.000839	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000691	0.000824	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—JUP—prostate cancer	0.000689	0.000822	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—WNT4—prostate cancer	0.000689	0.000822	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—ANXA1—prostate cancer	0.000662	0.000789	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MC2R—prostate cancer	0.000658	0.000784	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—RALBP1—prostate cancer	0.000658	0.000784	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PTHLH—prostate cancer	0.000639	0.000762	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PRKACB—prostate cancer	0.000626	0.000746	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CALCA—prostate cancer	0.00062	0.000739	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PPP3CA—prostate cancer	0.00061	0.000727	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CXCL12—prostate cancer	0.000605	0.000722	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—ANXA1—prostate cancer	0.000601	0.000716	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PENK—prostate cancer	0.000586	0.000699	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000583	0.000695	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	0.000575	0.000686	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CALCA—prostate cancer	0.000563	0.000671	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GHR—prostate cancer	0.000559	0.000666	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—PIK3CA—prostate cancer	0.000558	0.000665	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PRKCQ—prostate cancer	0.000552	0.000658	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CXCL12—prostate cancer	0.00055	0.000655	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000549	0.000654	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.000544	0.000648	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NRP1—prostate cancer	0.000536	0.000639	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—ADRB2—prostate cancer	0.000519	0.000619	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—VAV3—prostate cancer	0.000506	0.000604	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PRKCQ—prostate cancer	0.000502	0.000598	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.000499	0.000595	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—VIP—prostate cancer	0.000498	0.000594	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GNRH1—prostate cancer	0.000498	0.000594	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—ITPR1—prostate cancer	0.000491	0.000586	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—LPAR1—prostate cancer	0.000483	0.000575	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRP—prostate cancer	0.000483	0.000575	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PLCB2—prostate cancer	0.000478	0.000569	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—LRP2—prostate cancer	0.000478	0.000569	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—ADRB2—prostate cancer	0.000472	0.000562	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CX3CL1—prostate cancer	0.000469	0.000558	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—P4HB—prostate cancer	0.000469	0.000558	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—VAV3—prostate cancer	0.00046	0.000548	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HIST1H2BG—prostate cancer	0.00046	0.000548	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PDE4D—prostate cancer	0.000456	0.000543	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRB7—prostate cancer	0.000456	0.000543	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—ITPR1—prostate cancer	0.000446	0.000532	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HIST1H4H—prostate cancer	0.000444	0.000529	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CXCL8—prostate cancer	0.000444	0.000529	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.000442	0.000527	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GNG5—prostate cancer	0.000434	0.000517	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PTHLH—prostate cancer	0.000378	0.00045	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TGFBR1—prostate cancer	0.000378	0.00045	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—AKR1C3—prostate cancer	0.000372	0.000443	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PRKACB—prostate cancer	0.00037	0.00044	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—THBS1—prostate cancer	0.00036	0.000429	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PPP3CA—prostate cancer	0.00036	0.000429	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ANXA1—prostate cancer	0.000355	0.000423	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PRKCZ—prostate cancer	0.000349	0.000415	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PIK3CG—prostate cancer	0.000341	0.000406	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PARP1—prostate cancer	0.000337	0.000401	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGFR4—prostate cancer	0.000337	0.000401	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CALCA—prostate cancer	0.000332	0.000396	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CXCL12—prostate cancer	0.000325	0.000387	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PIK3CG—prostate cancer	0.000309	0.000369	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CASP9—prostate cancer	0.000306	0.000365	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PIK3CD—prostate cancer	0.000299	0.000357	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PRKCQ—prostate cancer	0.000296	0.000353	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NGFR—prostate cancer	0.000296	0.000353	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MAP3K7—prostate cancer	0.000293	0.000349	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGF10—prostate cancer	0.000282	0.000336	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ADRB2—prostate cancer	0.000279	0.000332	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—JAK2—prostate cancer	0.000275	0.000328	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—MAP2K1—prostate cancer	0.000274	0.000326	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PIK3CD—prostate cancer	0.000272	0.000324	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—VAV3—prostate cancer	0.000272	0.000324	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TGFBR2—prostate cancer	0.000268	0.000319	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ITPR1—prostate cancer	0.000264	0.000314	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PIK3CB—prostate cancer	0.000261	0.000311	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IGF1R—prostate cancer	0.000252	0.0003	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	0.000251	0.000299	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—JAK2—prostate cancer	0.00025	0.000297	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—LPL—prostate cancer	0.000242	0.000288	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—IL2—prostate cancer	0.00024	0.000286	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PDGFRB—prostate cancer	0.000239	0.000285	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	0.000237	0.000283	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ITGB3—prostate cancer	0.000233	0.000278	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CXCL8—prostate cancer	0.000228	0.000272	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ERBB3—prostate cancer	0.000226	0.00027	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGFR2—prostate cancer	0.000226	0.000269	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—IL2—prostate cancer	0.000218	0.000259	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TERT—prostate cancer	0.000217	0.000259	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HIF1A—prostate cancer	0.000207	0.000247	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—LEP—prostate cancer	0.000202	0.000241	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CAV1—prostate cancer	0.000201	0.000239	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—KDR—prostate cancer	0.000198	0.000236	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ESR1—prostate cancer	0.000193	0.00023	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—BAD—prostate cancer	0.000189	0.000225	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—APC—prostate cancer	0.000183	0.000218	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PIK3CG—prostate cancer	0.000183	0.000218	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—EGF—prostate cancer	0.000181	0.000215	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IRS1—prostate cancer	0.000181	0.000215	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GSK3B—prostate cancer	0.000175	0.000209	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—INS—prostate cancer	0.000173	0.000206	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CREBBP—prostate cancer	0.000169	0.000202	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IGF1—prostate cancer	0.000167	0.000199	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—EGFR—prostate cancer	0.000166	0.000198	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MAP2K1—prostate cancer	0.000162	0.000193	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PIK3CD—prostate cancer	0.000161	0.000191	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	0.000159	0.00019	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SERPINE1—prostate cancer	0.000159	0.000189	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—KRAS—prostate cancer	0.000157	0.000187	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGF2—prostate cancer	0.000154	0.000183	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NOS3—prostate cancer	0.000152	0.000181	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—JAK2—prostate cancer	0.000147	0.000176	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	0.000145	0.000172	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MDM2—prostate cancer	0.000144	0.000172	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ERBB2—prostate cancer	0.000142	0.000169	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PIK3CB—prostate cancer	0.00014	0.000167	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CXCL8—prostate cancer	0.000135	0.00016	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CDKN1B—prostate cancer	0.000131	0.000157	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—AKT1—prostate cancer	0.00013	0.000155	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CASP3—prostate cancer	0.000129	0.000154	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IL2—prostate cancer	0.000129	0.000153	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—IL6—prostate cancer	0.000128	0.000153	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCND1—prostate cancer	0.000125	0.000149	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CTNNB1—prostate cancer	0.000124	0.000148	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MMP9—prostate cancer	0.000122	0.000145	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CDKN1A—prostate cancer	0.000121	0.000145	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PTEN—prostate cancer	0.000121	0.000144	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—AKT1—prostate cancer	0.000118	0.000141	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—EP300—prostate cancer	0.000115	0.000138	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SRC—prostate cancer	0.000112	0.000134	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—VEGFA—prostate cancer	0.000109	0.00013	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—STAT3—prostate cancer	0.000108	0.000129	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MYC—prostate cancer	0.000101	0.00012	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TGFB1—prostate cancer	0.0001	0.00012	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—EGFR—prostate cancer	9.84e-05	0.000117	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—KRAS—prostate cancer	9.29e-05	0.000111	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PIK3CA—prostate cancer	8.54e-05	0.000102	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TP53—prostate cancer	8.26e-05	9.84e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IL6—prostate cancer	7.56e-05	9.01e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—AKT1—prostate cancer	6.97e-05	8.31e-05	CbGpPWpGaD
